Singapore markets open in 2 hours 50 minutes

BioCryst Pharmaceuticals, Inc. (BCRX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
4.2100-0.1700 (-3.88%)
At close: 04:00PM EDT
4.2385 +0.03 (+0.68%)
After hours: 05:39PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts11111110
Avg. Estimate-0.21-0.16-0.62-0.34
Low estimate-0.28-0.32-0.84-0.76
High estimate-0.14-0.06-0.26-0.11
Year ago EPS-0.28-0.4-1.18-0.62
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts10101110
Avg. Estimate85.8M98.08M394.99M475.7M
Low estimate83.53M94.64M382.08M398M
High estimate87.41M101.53M403.01M510.06M
Year ago sales68.78M82.49M331.41M394.99M
Sales growth (year/est)24.70%18.90%19.20%20.40%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.3-0.23-0.23-0.24
Actual EPS-0.28-0.4-0.19-0.31
Difference0.02-0.170.04-0.07
Surprise %6.70%-73.90%17.40%-29.20%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.21-0.16-0.62-0.34
7 days ago-0.21-0.16-0.62-0.34
30 days ago-0.21-0.16-0.61-0.34
60 days ago-0.22-0.16-0.72-0.39
90 days ago-0.22-0.16-0.72-0.39
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 days111N/A
Growth estimatesBCRXIndustrySector(s)S&P 500
Current qtr.25.00%N/AN/AN/A
Next qtr.60.00%N/AN/AN/A
Current year47.50%N/AN/AN/A
Next year45.20%N/AN/AN/A
Next 5 years (per annum)44.80%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A